Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Long-Term Investments (2021 - 2025)

Korro Bio's Long-Term Investments history spans 4 years, with the latest figure at $10.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments fell 72.86% year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Dec 2025, down 72.86%, and an annual FY2025 reading of $10.0 million, down 72.86% over the prior year.
  • Long-Term Investments for Q4 2025 was $10.0 million at Korro Bio, roughly flat from $10.0 million in the prior quarter.
  • The five-year high for Long-Term Investments was $37.0 million in Q4 2024, with the low at $6.6 million in Q2 2021.
  • Average Long-Term Investments over 4 years is $18.6 million, with a median of $12.4 million recorded in 2021.
  • Biggest YoY gain for Long-Term Investments was 23.33% in 2025; the steepest drop was 72.86% in 2025.
  • Tracing KRRO's Long-Term Investments over 4 years: stood at $11.7 million in 2021, then plummeted by 36.77% to $7.4 million in 2022, then skyrocketed by 398.77% to $37.0 million in 2024, then plummeted by 72.86% to $10.0 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Long-Term Investments are $10.0 million (Q4 2025), $10.0 million (Q3 2025), and $23.3 million (Q2 2025).